First FDA Approved Gene Therapies for Sickle Cell Anemia Cost Millions
The FDA permitted the primary gene therapies for sickle cell anemia.The 2 permitted therapies, Casgevy and Lyfgenia, will price $2.2 ...
The FDA permitted the primary gene therapies for sickle cell anemia.The 2 permitted therapies, Casgevy and Lyfgenia, will price $2.2 ...
Copyright © 2022 - Lebanon Hub.
Copyright © 2022 - Lebanon Hub.